The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors

Keyphrases

• Clinical Outcomes 100%
• Telomerase 100%
• Human Telomerase 100%
• Neuroblastic Tumors 100%
• Telomerase Expression 37%
• Tumor 31%
• Advanced Stage 18%
• MIB1 12%
• Ganglioneuroblastoma 12%
• In Situ Hybridization 6%
• Clinical Prognosis 6%
• Metastatic Disease 6%
• Cell Proliferation 6%
• Disease Progression 6%
• Excellent Outcome 6%
• Histopathological Features 6%
• Antisense RNA 6%
• N-Myc 6%
• Favorable Outcome 6%
• Favorable Prognosis 6%
• Neuroblastoma 6%
• Adverse Outcomes 6%
• Ribonucleoprotein 6%
• Aggressive Behavior 6%
• Schwann Cells 6%
• Ganglioneuroma 6%
• Behavioral Outcomes 6%
• Proliferation Marker 6%
• Ganglion Cells 6%
• Adverse Clinical Outcomes 6%
• Cell Immortalization 6%
• Limited Capacity 6%
• RNA Probe 6%
• Unpredictable Behavior 6%
• Tumor Section 6%
• Early-stage Tumor 6%
• Persistent Disease 6%

Medicine and Dentistry

• Telomerase 100%
• Tumor 100%
• Ganglioneuroblastoma 16%
• Neoplasm 11%
• Diseases 5%
• Metastatic Carcinoma 5%
• Recurrent Disease 5%
• Cancer Staging 5%
• Biological Product 5%
• Disease Exacerbation 5%
• Cell Proliferation 5%
• Complementary RNA 5%
• Downregulation 5%
• In Situ Hybridization 5%
• Adverse Outcome 5%
• Ribonucleoprotein 5%
• Enzyme 5%
• Schwann Cell 5%
• Ganglioneuroma 5%
• Ganglion 5%
• Uridine Triphosphate 5%
• Sulfur 35 5%

Neuroscience

• Telomerase 100%
• Cell Proliferation 5%
• Behavior (Neuroscience) 5%
• In Situ Hybridization 5%
• Antisense RNA 5%
• Neuroblastoma 5%
• N-Myc 5%
• Uridine Triphosphate 5%
• Ganglion Cell 5%
• Ribonucleoprotein 5%
• Enzyme 5%
• Schwann Cell 5%